Discover CKD-CVMD TA Payer and RWE Studies
Research payments
$703,269
Through program year 2024, $703,269 in research payments was reported against Discover CKD-CVMD TA Payer and RWE Studies, across 58 payments.
- Paid by (largest first)
- AstraZeneca AB; AstraZeneca UK Limited
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $3,725 | 2 |
| 2023 | Research | $203,348 | 12 |
| 2022 | Research | $244,840 | 18 |
| 2021 | Research | $130,653 | 14 |
| 2020 | Research | $111,089 | 10 |
| 2019 | Research | $9,614 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Rahul Pandey Houston, TX Named on 5 payments
- German Hernandez El Paso, TX Named on 5 payments
- Neil Kumar Roseburg, OR Named on 4 payments
- Tareq Nassar San Antonio, TX Named on 4 payments
- Steven Fishbane Great Neck, NY Named on 4 payments
- Ramin Sam San Francisco, CA Named on 4 payments
- Matthew Abramowitz Bronx, NY Named on 3 payments
- Piotr Lazowski Plymouth, MA Named on 3 payments
- Chao-Huang Sun Riverside, CA Named on 3 payments
- Sayed Husain Altamonte Springs, FL Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.